面对证据：儿童和青少年的抗抑郁治疗 - Suppr

Facing the evidence: antidepressant treatment in children and adolescents.

作者信息

Garland E Jane

机构信息

Mood and Anxiety Disorders Clinic, British Columbia's Children's Hospital, University of British Columbia, Vancouver BC.

出版信息

CMAJ. 2004 Feb 17;170(4):489-91.

PMID:14970097

原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC332716/

Abstract

摘要

相似文献

Facing the evidence: antidepressant treatment in children and adolescents.

CMAJ. 2004 Feb 17;170(4):489-91.

Antidepressants and adverse effects in young patients: uncovering the evidence.

CMAJ. 2004 Feb 17;170(4):487-9.

UK psychiatrists question SSRI warnings for under-18s.

CMAJ. 2004 Feb 17;170(4):455.

Potential effects of antidepressant agents on the growth and development of children and adolescents.

J Psychosoc Nurs Ment Health Serv. 2005 Jan;43(1):22-35. doi: 10.3928/02793695-20050101-06.

Questions about SSRI antidepressant drug regulation.

Lancet. 2004;364(9434):577. doi: 10.1016/S0140-6736(04)16838-4.

Do selective serotonin reuptake inhibitors cause suicide? Antidepressant prescribing to children and adolescents by GPs has fallen since CSM advice.

BMJ. 2005 May 14;330(7500):1151. doi: 10.1136/bmj.330.7500.1151.

Are selective serotonin reuptake inhibitors a risk factor for adolescent suicide?

Can J Psychiatry. 2009 Feb;54(2):69-71; discussion 76-7. doi: 10.1177/070674370905400201.

[Antidepressant agents in the therapy of severe depression in adolescents].

Duodecim. 1999;115(1):36-44.

FDA questions antidepressant safety for children.

Lancet. 2003 Nov 8;362(9395):1558. doi: 10.1016/S0140-6736(03)14787-3.

Antidepressants and suicide: rising prescription rate does not mean rising rate of new users.

BMJ. 2004 Aug 21;329(7463):461; author reply 461-2. doi: 10.1136/bmj.329.7463.461.

引用本文的文献

Antidepressant Use in Medicaid-Insured Youth: Trends, Covariates, and Future Research Needs.

Front Psychiatry. 2020 Mar 13;11:113. doi: 10.3389/fpsyt.2020.00113. eCollection 2020.

Exploring the Potential Antidepressant Mechanisms of TNFα Antagonists.

Front Neurosci. 2019 Feb 11;13:98. doi: 10.3389/fnins.2019.00098. eCollection 2019.

Defining publication bias: protocol for a systematic review of highly cited articles and proposal for a new framework.

Syst Rev. 2013 May 21;2:34. doi: 10.1186/2046-4053-2-34.

Antidepressant use in children and adolescents: Practice touch points to guide paediatricians.

Paediatr Child Health. 2011 Nov;16(9):549-53. doi: 10.1093/pch/16.9.549.

Adverse drug reactions from psychotropic medicines in the paediatric population: analysis of reports to the Danish Medicines Agency over a decade.

BMC Res Notes. 2010 Jun 23;3:176. doi: 10.1186/1756-0500-3-176.

Reporting bias in medical research - a narrative review.

Trials. 2010 Apr 13;11:37. doi: 10.1186/1745-6215-11-37.

Antidepressant use in adolescence: We're asking the wrong questions.

Paediatr Child Health. 2004 Oct;9(8):539-540. doi: 10.1093/pch/9.8.539.

Treating depressed children with antidepressants: more harm than benefit?

J Clin Psychol Med Settings. 2008 Jun;15(2):92-7. doi: 10.1007/s10880-008-9108-9.

Off-label psychopharmacologic prescribing for children: history supports close clinical monitoring.

Child Adolesc Psychiatry Ment Health. 2008 Sep 15;2(1):24. doi: 10.1186/1753-2000-2-24.

Manufacturing consensus.

Cult Med Psychiatry. 2006 Jun;30(2):135-56. doi: 10.1007/s11013-006-9013-3.

本文引用的文献

Paroxetine (Paxil, Seroxat): increased risk of suicide in pediatric patients.

CMAJ. 2003 Sep 2;169(5):446.

Efficacy of sertraline in the treatment of children and adolescents with major depressive disorder: two randomized controlled trials.

JAMA. 2003 Aug 27;290(8):1033-41. doi: 10.1001/jama.290.8.1033.

A systematic chart review of the nature of psychiatric adverse events in children and adolescents treated with selective serotonin reuptake inhibitors.

J Child Adolesc Psychopharmacol. 2003 Summer;13(2):143-52. doi: 10.1089/104454603322163862.

Scope and impact of financial conflicts of interest in biomedical research: a systematic review.

JAMA. 2003;289(4):454-65. doi: 10.1001/jama.289.4.454.

A national survey of provisions in clinical-trial agreements between medical schools and industry sponsors.

N Engl J Med. 2002 Oct 24;347(17):1335-41. doi: 10.1056/NEJMsa020349.

Fluoxetine for acute treatment of depression in children and adolescents: a placebo-controlled, randomized clinical trial.

J Am Acad Child Adolesc Psychiatry. 2002 Oct;41(10):1205-15. doi: 10.1097/00004583-200210000-00010.

Rising prevalence of antidepressants among US youths.

Pediatrics. 2002 May;109(5):721-7. doi: 10.1542/peds.109.5.721.

Efficacy of paroxetine in the treatment of adolescent major depression: a randomized, controlled trial.

J Am Acad Child Adolesc Psychiatry. 2001 Jul;40(7):762-72. doi: 10.1097/00004583-200107000-00010.

Practice parameters for the assessment and treatment of children and adolescents with depressive disorders. AACAP.

J Am Acad Child Adolesc Psychiatry. 1998 Oct;37(10 Suppl):63S-83S. doi: 10.1097/00004583-199810001-00005.

Childhood and adolescent depression: a review of the past 10 years. Part II.

J Am Acad Child Adolesc Psychiatry. 1996 Dec;35(12):1575-83. doi: 10.1097/00004583-199612000-00008.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

Facing the evidence: antidepressant treatment in children and adolescents.

作者信息

机构信息

出版信息

相似文献

引用本文的文献

本文引用的文献

文献AI研究员

用中文搜PubMed

文档翻译

Suppr 超能文献

相似文献

引用本文的文献

本文引用的文献